Assertio (NASDAQ:ASRT – Get Rating) had its price target increased by equities research analysts at BWS Financial from $6.00 to $8.00 in a report released on Friday, The Fly reports. The firm currently has a “buy” rating on the stock. BWS Financial’s price target would suggest a potential upside of 28.82% from the stock’s current price.
A number of other equities analysts have also issued reports on the stock. StockNews.com upgraded shares of Assertio from a “hold” rating to a “buy” rating in a research report on Wednesday, November 9th. Lake Street Capital assumed coverage on shares of Assertio in a research report on Monday, November 7th. They set a “buy” rating and a $7.00 target price on the stock. Four investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of $7.50.
Assertio Price Performance
NASDAQ:ASRT opened at $6.21 on Friday. The firm has a market cap of $299.88 million, a PE ratio of 11.50, a price-to-earnings-growth ratio of 1.15 and a beta of 1.38. Assertio has a 12 month low of $1.86 and a 12 month high of $6.34. The company has a quick ratio of 1.22, a current ratio of 1.37 and a debt-to-equity ratio of 0.49. The company’s 50-day moving average price is $4.50 and its two-hundred day moving average price is $3.37.
Hedge Funds Weigh In On Assertio
Assertio Company Profile
Assertio Holdings, Inc engages in the provision of commercial pharmaceutical products. Its commercial portfolio of branded products focuses on the following areas: neurology, hospital, and pain and inflammation. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.
Further Reading
- Get a free copy of the StockNews.com research report on Assertio (ASRT)
- MarketBeat Week in Review – 2/27 – 3/3
- The 3 Most Upgraded Stocks Are Reversing
- How to Find Blue Chip Dividend Stocks
- Zscaler, Inc Plummets, Is It Time To Buy The Dip?
- What is a Good Dividend Yield? How to Decide
Receive News & Ratings for Assertio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assertio and related companies with MarketBeat.com's FREE daily email newsletter.